Monoclonal Antibodies: Synthetic antibodies designed to target specific proteins in cancer cells.
Tyrosine Kinase Inhibitors (TKIs): Block signals that promote cancer cell growth and division.
Angiogenesis Inhibitors: Disrupt the formation of new blood vessels that supply nutrients to tumors.
Proteasome Inhibitors: Interfere with the normal breakdown of proteins within cancer cells.
Infusion Therapy: Some targeted therapies are administered intravenously in a clinic or hospital setting.
Oral Medications: Many targeted therapies are available in pill or capsule form, allowing convenient at-home administration.
Combination Therapies: Targeted therapies may be combined with other treatment modalities for synergistic effects, especially in complex or advanced-stage cancers.
Monitoring Response: Regular assessments, including imaging and laboratory tests, are conducted to evaluate the response to targeted therapies.
Side Effect Management: Our care team adopts a personalized approach to managing side effects, ensuring a balance between therapeutic efficacy and patient well-being.
Patient Education: Comprehensive information is provided to patients, empowering them with knowledge about targeted therapy, its mechanisms, and potential side effects.
Emotional and Psychological Support: Guru Cancer Center offers resources and support services to address the emotional and psychological aspects of targeted therapy.
Nutritional Guidance: Nutritional counseling is integrated into the care plan to support overall well-being during and after targeted therapy.
4 /120-F, PandikovilRing Road,
Airport – Mattuthavani Ring Rd,
Madurai
Tamilnadu – 625107.
